We expect the challenge to persist in Medicare
If your blood sugar goes too low, you will die
The STEP 1 trial showed semaglutide 2.4 mg led to 14.9% weight loss over 68 weeks, while SURMOUNT-1 showed tirzepatide achieved up to 20.9% weight reductionapproaching bariatric surgery outcomes.[6] The SELECT trial (17,604 patients) found semaglutide reduced cardiovascular death, non-fatal heart attack, and non-fatal stroke by 20% and all-cause mortality by 19%, suggesting direct cardioprotective effects beyond weight loss.[4] In STEP-HFpEF, semaglutide produced 13.3% weight loss in heart failure patients and improved symptoms and physical function
OAC has engaged with meetings with dozens of groups around the issue of compounding to see if we can identify who is compounding correctly and who isnt
And I want to experience everything, so its important for me to keep myself in check
Significant weight loss typically begins within the first month, with clinical studies showing average weight loss of 15-20% over 6-12 months with consistent treatment and lifestyle modifications